Showing results (111-120 of 132) with videos related to
Sort By:
Pageof 14
The European Journal of Medicine|July 1, 1992
Changes of serum neopterin, beta 2-microglobulin and interferon-gamma in patients with chronic hepatitis C treated with interferon-alpha 2bD Fuchs, G Norkrans, R Wejstal, et al.Journal of Viral Hepatitis|May 30, 2008
Lower-than-standard dose peg-IFN alfa-2a for chronic hepatitis C caused by genotype 2 and 3 is sufficient when given in combination with weight-based ribavirinO Weiland, A Hollander, L Mattsson, et al.Journal of Medical Virology|March 13, 1998
GBV-C/HGV infection in hepatitis C virus-infected deferred Swedish blood donorsS Shev, P Björkman, G Norkrans, et al.Digestive Diseases and Sciences|December 1, 1996
Interferon-ribavirin combination therapy for chronic hepatitis CS W Schalm, J T Brouwer, L Chemello, et al.Hepatology (Baltimore, Md.)|February 1, 1994
High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-alpha 2b for 60 weeksO Reichard, U Foberg, A Frydén, et al.Gastroenterology|December 31, 1998
Limited humoral immunity in hepatitis C virus infectionM Chen, M Sällberg, A Sönnerborg, et al.Scandinavian Journal of Infectious Diseases|January 1, 1995
Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infectionO Weiland, M Chen, G Lindh, et al.Scandinavian Journal of Infectious Diseases|January 1, 1995
Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infectionO Weiland, M Chen, G Lindh, et al.Infection|September 1, 1995
HCV genotypes in Swedish blood donors as correlated to epidemiology, liver disease and hepatitis C virus antibody profileS Shev, A Widell, U Foberg, et al.Clinical Immunology and Immunopathology|December 1, 1986
Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition (LMI) in infectious mononucleosis (IM). I. Kinetics and response to a membrane protein on EBV-transformed cellsR Szigeti, L Timar, O Weiland, et al.Pageof 14